http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이영섭,서경훈,박인기,Young Seob Lee,MD,Kyung Hoon Seo,MD,In Ki Park,MD 대한안과학회 2011 대한안과학회지 Vol.52 No.10
Purpose: To report a case of unilateral mydriasis after accidental exposure to an Angel’s trumpet leaf. Case summary: A 53-year-old woman visited the Eye Department complaining of blurred vision and difficulty in light adaptation in the left eye of 1-week duration. The best corrected visual acuity was 20/20 in both eyes and other ophthalmological findings were considered normal except for dilation of the left pupil and a decrease in light reflex. The patient was initially unaware of any cause of her eye problems, but when asked specifically, the patient remembered an Angel’s trumpet leaf brushing against her left eye when she carried the plants. There were no other previous medical or drug histories, thus the Angel’s trumpet was considered as the cause for the unilateral mydriasis. The patient’s progress was followed for a week, her symptoms improved and the pupil size and reflex returned to normal. Conclusions: The cultivation of Angel’s trumpet has become increasingly popular in Korea in recent years. The present case emphasizes the importance of an accurate and detailed history regarding specific contact history with plants like Angel’s trumpet in otherwise healthy patients affected by unilateral mydriasis. J Korean Ophthalmol Soc 2011;52(10):1259-1261
망막정맥폐쇄 환자에서 유리체내 베바시주맙 주입술의 2년 임상 결과
이영섭,김무상,유승영,곽형우,Young Seob Lee,Moo Sang Kim,Seung Young Yu,Hyung Woo Kwak 대한안과학회 2011 대한안과학회지 Vol.52 No.9
Purpose: The authors evaluated the 2-year clinical results of intravitreal bevacizumab injection in retinal vein occlusion (RVO). Methods: Thirty-two eyes of 32 patients treated with an intravitreal bevacizumab injection of 1.25 mg (0.05 ml) for RVO (branch RVO: 22 eyes, central RVO: 10 eyes), repeated 3 times at a 6-week interval and were available for a follow-up period of at least 2 years were retrospectively reviewed. Best-corrected visual acuity (BCVA) before treatment and 6, 12, and 24 months after 3 serial injections, was recorded. The optical coherence tomography (OCT) results were analyzed to identify prognostic factors for recurrent macular edema that needed reinjection. Results: Two years after the treatment, mean BCVA was significantly improved (<em>p</em> = 0.000). Out of 32 eyes, 16 (branch RVO: 8 eyes; central RVO: 8 eyes) needed reinjection because of recurrent macular edema. In central RVO, a significantly high reinjection rate was shown in serous retinal detachment (SRD) compared with cystoid macular edema (CME) as identified in OCT findings (<em>p</em> = 0.049). Additionally, in branch RVO, a high reinjection rate was shown in SRD, although statistically not significant (<em>p</em> = 0.375). Conclusions: In patients with RVO, a significant visual improvement was maintained for at least 2 years after intravitreal bevacizumab injection. Based on OCT results, SRD showed a high reinjection rate compared with CME in CRVO. J Korean Ophthalmol Soc 2011;52(9):1039-1047